ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

ClinicalTrials.gov ID: NCT07091630

Public ClinicalTrials.gov record NCT07091630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 2:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Study identification

NCT ID
NCT07091630
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
argenx
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Empasiprubart IV Biological
  • Placebo IV Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2025
Primary completion
Oct 6, 2027
Completion
Jan 22, 2031
Last update posted
May 7, 2026

2025 – 2031

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Samir Macwan, M.D., Inc. (S corporation) Rancho Mirage California 92270 Recruiting
Colorado Springs Neurological Associates Colorado Springs Colorado 80907 Recruiting
Medstar Health Research Institute Washington D.C. District of Columbia 20010 Recruiting
Gables Neurology Miami Florida 33133 Recruiting
Aqualane Clinical Research Naples Florida 34105 Recruiting
Paradigm Health System Slidell Louisiana 70458 Recruiting
Penn Medicine University City Philadelphia Pennsylvania 19104-5545 Recruiting
National Neuromuscular Research Institute Austin Texas 78756 Recruiting
NeuroCarePlus Houston Texas 77094 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07091630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07091630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →